The One Big Beautiful Bill Act, signed into law by President Donald Trump, has polarized opinions in the healthcare community due to its sweeping changes. Central to the apprehension is its significant reduction in Medicaid spending and the eradication of Affordable Care Act subsidies. These
What if the secret to faster and more effective cancer treatments isn't found in conventional laboratories but within the algorithms of artificial intelligence instead? Drug development has long been a drawn-out process, often taking over a decade to bring a new medication from concept to market.
The ongoing exploration of the Thymagen peptide propels the scientific community into a fascinating investigation of its possible impacts on several critical biological functions. This small but potentially powerful thymic-derived compound has become an exciting focal point for researchers hoping
A new study centered around planned cesarean sections (C-sections) and their association with childhood leukemia sparks significant discussions. With rising rates of elective C-sections globally, healthcare professionals and policymakers are intrigued by findings suggesting heightened risks for
In the rapidly evolving landscape of healthcare and artificial intelligence, Ivan Kairatov stands out as a leading voice, particularly when it comes to understanding the complex intersection of bioethics, law, and technology in the biopharma industry. His extensive experience in research and
India's healthcare landscape is experiencing transformative changes with recent advancements, including the inauguration of the Phenome India "National Biobank." This ambitious initiative, spearheaded by Dr. Jitendra Singh, underscores a pivotal moment for personalized healthcare in the country.
The process of drug discovery and development, often stretching over decades, is one of the most demanding and expensive tasks faced by the pharmaceutical industry. Recently, Artificial Intelligence (AI) has emerged as a promising tool to streamline this process, promising dramatic reductions in
Amidst advancing medical treatments for colorectal cancer, a less-discussed byproduct of the disease is its profound impact on women's sexual health. This emerging issue is gaining attention as researchers endeavor to understand how female survivors cope with post-treatment sexual challenges.
The prevalence of diabetes presents an escalating health crisis with significant implications for individuals and healthcare systems globally. Among prediabetes patients, effective prevention strategies are vital to curb the increasing rates of Type 2 diabetes. Long-term studies underscore that
Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised
